Which statement best describes how success is measured in an evidence-based treatment plan for SUD?

• A. Only symptom resolution matters.
• B. Short-term outcomes are all that matter.
• C. Improvements in functioning only.
• D. Retention in treatment, reduction in use, abstinence, improvements in functioning, fewer hospitalizations, and progress metrics.

Answer: (D)

Measuring success in evidence-based SUD treatment means looking at multiple areas over time, not just one symptom or short-term change. A solid plan tracks engagement and staying in treatment (retention), reductions in substance use or achieving abstinence, and real-life improvements in functioning such as work, relationships, and daily living. It also considers health outcomes like fewer hospitalizations and uses progress metrics to show how goals are being met. This broad approach reflects what recovery looks like in real life and provides a clear signal about whether the treatment is helping.

Retention in treatment matters because staying engaged increases the chance of meaningful change and allows for ongoing adjustment of the plan. Reductions in use and abstinence directly relate to harm reduction and health improvements. Improvements in functioning show that gains go beyond what’s visible in symptoms, touching everyday life. Fewer hospitalizations indicate better overall health and safety. Progress metrics give a tangible track record of progress and help clinicians fine-tune interventions.

If a measure focuses only on symptoms, or only on short-term results, it can miss how well someone is actually stabilizing in daily life or whether use is creeping back. If it looks only at functioning, it might overlook ongoing use or relapse risk. By combining all these elements, the treatment plan aligns with how recovery unfolds in real life and provides the most reliable picture of success.